Key result
Neonatal inoculation of rhesus monkeys with Mason-Pfizer monkey virus frequently induced pneumonia, enteritis, lymphadenopathy, thymic atrophy, and a disease suggestive of an autoimmune response.
Why the study?
Does neonatal inoculation with Mason-Pfizer monkey virus induce disease in infant rhesus monkeys?
Does neonatal inoculation with Mason-Pfizer monkey virus induce disease in infant rhesus monkeys?
This is the authors' abstract. We don't add key points for this paper.
Rhesus monkeys neonatally inoculated with Mason-Pfizer monkey virus (M-PMV) and virus-infected cells frequently developed viral and/or bacterial pneumonia and enteritis. Three characteristic hematologic patterns occurred among the inoculated animals and correlated well with the probability of survival. Postmortem examination of the animals revealed lymphadenopathy and thymic atrophy. M-PMV was present in lymph nodes, blood, brain, spleen, thymus, kidneys, and bone marrow. The disease induced in some animals had characteristics suggestive of a slow-virus-induced autoimmune response.
Answers are grounded in this paper and cite their sources.
Neonatal inoculation of rhesus monkeys with M-PMV induces a disease characterized by pneumonia, enteritis, and lymphoid changes suggestive of a slow-virus-induced autoimmune response.
No takes yet. Share an insight, caveat, or question.
Fine et al. (1975) studied Mason-Pfizer monkey virus (M-PMV) infection. Inoculation with Mason-Pfizer monkey virus (M-PMV) and virus-infected cells was evaluated on Development of viral and/or bacterial pneumonia and enteritis. Neonatal inoculation of rhesus monkeys with Mason-Pfizer monkey virus frequently induced pneumonia, enteritis, lymphadenopathy, thymic atrophy, and a disease suggestive of an autoimmune response.
Synapse has enriched 10 related papers. Consider them for comparative context: